Romina Mayra Lasagni Vitar

Prof. Romina Mayra Lasagni Vitar

Cornea and Ocular Surface Disease Unit, Eye Repair Lab, IRCCS San Raffaele Scientific Institute, Milan, Italy.
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
PRPaolo Rama
Paolo Rama
GFGiulio Ferrari
Giulio Ferrari

1 March 2021 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
MBMarco Barbariga
Marco Barbariga
PFPhilippe Fonteyne
Philippe Fonteyne
FBFabio Bignami
Fabio Bignami
PRPaolo Rama
Paolo Rama
GFGiulio Ferrari
Giulio Ferrari
Purpose: The purpose of this study was to test the role of substance P (SP) and its receptor neurokinin 1 (NK1R) on ocular surface pain. Methods: Eight-week-old C57BL6/N (wild type [WT]) and B6.Cg-Tac1tm1Bbm/J (TAC1-KO) male mice were used. 5 M NaCl was topically applied on the cornea, followed by topical fosaprepitant 2, 10, and 50 mg/mL; 4 mg/mL oxybuprocaine chloride, or 0.1% diclofenac. Th eye wiping test was used to quantify ocular surface pain. SP content was quantified in the tear fluid and trigeminal ganglia (TG), and TAC1 mRNA was assessed in the cornea. Corneas were immunostained for β3-tubulin and NK1R, or CD45, to quantify leukocyte infiltration. Results: TAC1-KO mice displayed a significant reduction of ocular pain (P < 0.001). Similarly, a single dose of 10 or 50 mg/mL fosaprepitant applied topically to WT mice reduced ocular pain as compared to vehicle (P < 0.001). Fosaprepitant 2 mg/mL, instead, induced corneal analgesia only when it was administered for 10 days, 6 times/day (P < 0.05). Diclofenac or oxybuprocaine reduced corneal nociception when compared to vehicle or fosaprepitant (P < 0.05). Fosaprepitant or oxybuprocaine groups showed lower SP content in tear secretions and TG (P < 0.05), and reduction in TAC1 mRNA (P < 0.05), and leukocyte infiltration (P < 0.05) in the cornea. Colocalization of NK1R and β3-tubulin was detected in mouse corneas. Conclusions: Topical administration of the NK1R antagonist fosaprepitant effectively reduces ocular surface nociception by decreasing SP release in the tear fluid and TG, and corneal leukocyte infiltration. Fosaprepitant repurposing shows promise for the treatment of ocular pain.

21 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
FBFilippo Bonelli
Filippo Bonelli
PRPaolo Rama
Paolo Rama
GFGiulio Ferrari
Giulio Ferrari
Keratoconus (KC) is a progressive corneal degeneration characterized by structural changes consisting of progressive thinning and steepening of the cornea. These alterations result in biomechanical weakening and, clinically, in vision loss. While the etiology of KC has been the object of study for over a century, no single agent has been found. Recent reviews suggest that KC is a multifactorial disease that is associated with a wide variety of genetic and environmental factors. While KC is typically considered a disease of the cornea, associations with systemic conditions have been well described over the years. In particular, nutritional and metabolic imbalance, such as the redox status, hormones, metabolites, and micronutrients (vitamins and metal ions), can deeply influence KC initiation and progression. In this paper, we comprehensively review the different nutritional (vitamins and minerals) and metabolic (hormones and metabolites) factors that are altered in KC, discussing their possible implication in the pathophysiology of the disease.

1 December 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
AAAilen G. Hvozda Arana
Ailen G. Hvozda Arana
NJNatasha S. Janezic
Natasha S. Janezic
TMTimoteo Marchini
Timoteo Marchini
JTJulia Tau
Julia Tau
SFSandra M. Ferreira
Sandra M. Ferreira

1 November 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
JTJulia Tau
Julia Tau
CRClaudia G. Reides
Claudia G. Reides
ABAlejandro Berra
Alejandro Berra
SFSandra M. Ferreira
Sandra M. Ferreira
SLSusana F. Llesuy
Susana F. Llesuy
Purpose: The aim of this study was to evaluate oxidative stress markers in human conjunctival epithelial cells (IOBA-NHC) exposed to diesel exhaust particles (DEP). Methods: Reactive oxygen (ROS) and nitrogen (RNS) species production; hydrogen peroxide (H2O2) levels; protein oxidation; antioxidant enzymes activities (superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GPx], glutathione S-transferase [GST], and glutathione reductase [GR]); total reactive antioxidant potential (TRAP); reduced (GSH) and oxidized glutathione (GSSG) were evaluated. Transmission electron microscopy was performed to evaluate DEP uptake. Results: Diesel exhaust particles were entrapped by membrane protrusions developed by IOBA-NHC. Cells exposed to DEP 50 and 100 μg/mL showed a significant increase in ROS, RNS, H2O2 levels, SOD, GPx, and GST compared with the control group. A significant decay in GR was observed in both groups, meanwhile CAT levels remained unchanged. The group exposed to DEP 100 μg/mL displayed a significant increase in protein oxidation. In both groups, TRAP was significantly reduced as well as the GSH/GSSG ratio. Conclusions: The decrease in nonenzymatic antioxidants and the compensatory increase of SOD, GPX, and GST activities are consequence of the increase in ROS and RNS production due to DEP exposure and its accumulation inside the cells. The decay in GR activity leads to the decrease in GSH/GSSG recycling. These results suggest that oxidative stress could play an important role in the development of DEP effects on human conjunctival epithelial cells.

1 June 2018 in Experimental Eye Research
Verified
Journal Article
Closed access
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
JTJulia Tau
Julia Tau
NJNatasha S. Janezic
Natasha S. Janezic
ATAgustina I. Tesone
Agustina I. Tesone
AAAilen G. Hvozda Arana
Ailen G. Hvozda Arana
SLSusana F. Llesuy
Susana F. Llesuy